| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | Feb 26, 2015 | Option Exercise | $3.67 | 100,000 | 367,200 | 53,810 | Mar 02, 2015, 05:34 PM | |
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | May 30, 2014 | Option Exercise | $5.25 | 4,218 | 22,145 | 8,028 | Feb 05, 2015, 05:33 PM | |
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | Nov 29, 2013 | Option Exercise | $5.34 | 3,810 | 20,345 | 3,810 | Feb 11, 2014, 07:32 AM | |
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | Jul 26, 2013 | Sale | $4.61 | 129,534 | 596,596 | 64,767 | Jul 29, 2013, 07:50 PM | |
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | Mar 11, 2013 | Sale | $4.17 | 55,370 | 230,616 | 27,685 | Mar 12, 2013, 08:26 PM | |
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | Jan 15, 2013 | Sale | $4.17 | 44,630 | 185,884 | 22,315 | Jan 18, 2013, 06:02 AM | |
| OREX | Orexigen Therapeutics, Inc. | Booth Mark D | Chief Commercial Officer | Jun 28, 2012 | Option Exercise | $3.66 | 206,618 | 756,222 | 103,309 | Jun 29, 2012, 06:58 PM |
Menu